![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Raltegravir (RAL) Resistant Isolates without Primary RAL Integrase (IN) Mutations are Cross-resistant to Elvitegravir (EVG) but not Dolutegravir (DTG)
|
|
|
Reported by Jules Levin
International Workshop on Antiviral Drug Resistance
June 3-7 2014, Berlin, Germany
MR Underwood1, J Horton1, F DeAnda1
1 GlaxoSmithKline, North Carolina, USA
![resist1.gif](../images/060614/060614-3/resist1.gif)
![resist2.gif](../images/060614/060614-3/resist2.gif)
![resist3.gif](../images/060614/060614-3/resist3.gif)
![resist4.gif](../images/060614/060614-3/resist4.gif)
![resist5.gif](../images/060614/060614-3/resist5.gif)
![resist6.gif](../images/060614/060614-3/resist6.gif)
![resist7.gif](../images/060614/060614-3/resist7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|